William P. Dole

机构：Novartis (United States)

发表论文 91 篇 · 总被引 4758 次 · h-index 38

代表论文

• Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi) (2009 · The Journal of Clinical Pharmacology · 被引 507)
• Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans (2008 · Circulation · 被引 165)
• Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren (2008 · The Journal of Clinical Pharmacology · 被引 103)
• Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure (2012 · Drug Discovery Today Therapeutic Strategies · 被引 83)
• Pharmacokinetics and Pharmacodynamics of Vildagliptin in Healthy Chinese Volunteers (2008 · The Journal of Clinical Pharmacology · 被引 63)
• Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects (2014 · Journal of Translational Medicine · 被引 57)